Technical note: utilization of various allotment strategies to evaluate variation and replications required to detect statistical significance in nursery pig research.

A total of 720 barrows (line 200 × 400, DNA genetics) were used in two 42-d nursery trials (initially 6.20 ±â€…0.12 kg and 5.63 ±â€…0.16 kg, respectively) to evaluate strategies for allotting pigs to pens in randomized controlled trials. At placement, the population was split into three cohorts with similar average weight and standard deviation and randomly assigned to one of the three allotment strategies. Strategy 1 (random) utilized a simple randomization strategy with each pig randomized to pens independent of all other pigs. Strategy 2 (body weight [BW] distribution) sorted each pig within the cohort into one of the five BW groups. One pig from each weight group was then randomly assigned to a pen such that distribution of BW within pen was uniform across pens. Strategy 3 (BW grouping) sorted pigs within the cohort into 3 BW categories: light, medium, and heavy. Within each BW category, pigs were randomized to pen to create pens of pigs from each BW category. Within each experiment, there were 72 pens with five pigs per pen and 24 pens per allotment strategy. For all strategies, once pigs were allotted to pens, pens were allotted to one of the two treatments for a concurrent trial. In experiment 1, environmental enrichment using ropes tied near the pan of the feeder was compared to a control with no enrichment. In experiment 2, treatment diets consisted of basal levels of Zn and Cu from the trace mineral premix for the duration of the study (110 and 17 mg/kg, respectively; control), or diets (supplemented control) with carbadox (50 g/ton; Mecadox, Phibro Animal Health, Teaneck, NJ) fed in phase 1 (days 0 to 22) and 2 (days 22 to 43), pharmacological levels of Zn and Cu (2,414 mg/kg Zn from ZnO; 168 mg/kg Cu from CuSO4) fed in phase 1, and only pharmacological levels of Cu (168 mg/kg Cu from CuSO4) fed in phase 2. These treatment designs were used to determine the impact on coefficient of variation (CV) and to estimate the number of replications required to find significant treatment differences based on allotment strategy. There were no meaningful allotment strategy × treatment interactions for either study. For between-pen CV, pigs allotted using BW distribution and BW grouping strategies had the lowest CV at allotment and final weight in both trials. For overall average daily gain in experiments 1 and 2 in experiment 2, the BW distribution strategy required the fewest replications to detect differences in performance. However, there is no meaningful difference between allotment strategies in replications required to detect significant differences for gain:feed ratio.

Decreasing variation between experimental units increases the likelihood of finding a statistically significant difference if one exists. Assignment of animals to experimental units (pens) may contribute to that variation. Therefore, the purpose of this trial was to investigate the effect that different methods of allotting pigs to pens (experimental unit) have on variation and in turn, the number of replications required to detect a significant difference of a given amount between treatments. The random strategy assigned pigs to pens in a completely random fashion. The body weight (BW) distribution strategy ordered pigs from lightest to heaviest and created five groups based on BW. Each pen was randomly assigned one pig from each of the five groups. The BW grouping strategy again ordered pigs from lightest to heaviest but split pigs into three groups based on BW and each pen was randomly assigned pigs from only one BW group such that there were pens of light pigs, pens of medium pigs, and pens of heavy pigs. Ultimately, the best allotment strategy depends on the parameter of interest. For final BW and overall ADG, the BW grouping method required the fewest pens to detect statistically significant differences.

Evaluating the effects of benzoic acid on nursery and finishing pig growth performance.

Three studies were conducted evaluating the use of benzoic acid in swine diets. In experiment 1, 350 weanling barrows (DNA 200 × 400; initially 5.9 ±â€…0.04 kg) were allotted to one of the five dietary treatments with 14 pens per treatment. Diets were fed in three phases: phase 1 from weaning to day 10, phase 2 from days 10 to 18, and phase 3 from days 18 to 38. Treatment 1 contained no benzoic acid throughout all three phases (weaning to day 42). Treatment 2 included 0.50% benzoic acid throughout all three phases. Treatment 3 contained 0.50% benzoic acid in phases 1 and 2, and 0.25% benzoic acid in phase 3. Treatment 4 contained 0.50% benzoic acid in phases 1 and 2, and no benzoic acid in phase 3. Treatment 5 contained 0.50% benzoic acid in phase 1, 0.25% benzoic acid in phase 2, and no benzoic acid in phase 3. For the overall period, pigs fed 0.50% in the first two phases and 0.25% benzoic acid in the final phase had greater (P < 0.05) average daily gain (average daily gain) than pigs fed no benzoic acid through all three phases, or pigs fed 0.50% in the first two phases and no benzoic acid in the final phase, with pigs fed the other treatments intermediate. Pigs fed 0.50% in the first two phases and 0.25% benzoic acid in the final phase had improved (P < 0.05) gain-to-feed ratio (G:F) compared with pigs fed no benzoic acid throughout all three phases, pigs fed 0.50% in the first two phases and no benzoic acid in the third phase, or pigs fed 0.50%, 0.25%, and no benzoic acid, respectively. For experiment 2, a 101-d trial was conducted using two groups of 1,053 finishing pigs (2,106 total pigs; PIC 337 × 1,050; initially 33.3 ±â€…1.9 kg). Dietary treatments were corn-soybean meal-dried distillers grains with solubles-based with the addition of none, 0.25%, or 0.50% benzoic acid. Overall, pigs fed increasing benzoic acid had a tendency for increased average daily feed intake (linear, P = 0.083) but decreased G:F (linear, P < 0.05). In experiment 3, 2,162 finishing pigs (DNA 600 × PIC 1050; initially 31.4 ±â€…2.2 kg) were used in a 109-d trial. Dietary treatments were formulated with or without 0.25% benzoic acid. For the overall experimental period, pigs fed benzoic acid had increased (P < 0.05) G:F. In summary, feeding benzoic acid elicits improved growth performance when fed throughout the entire nursery period while improved G:F in growing-finishing pigs was observed in one experiment, but not in the other.

Effects of increasing omega-3 fatty acids on growth performance, immune response, and mortality in nursery pigs.

Three experiments evaluated omega-3 fatty acids, provided by O3 trial feed, on nursery pig growth performance, mortality, and response to an LPS immune challenge or natural Porcine reproductive and respiratory virus (PRRSV) outbreak. In experiment 1, 350 pigs (241 × 600, DNA; initially 5.8 kg) were used. Pens of pigs were randomly assigned to one of the five dietary treatments containing increasing omega-3 fatty acids (0%, 1%, 2%, 3%, and 4% O3 trial feed) with 14 replications per treatment. On day 25, two pigs per pen were injected intramuscularly with 20 µg Escherichia coli LPS per kg BW and one pig per pen was injected with saline as a control. Body temperature was taken from all three pigs prior to and 2, 4, 6, and 12 h post-LPS challenge. Serum IL-1ß and TNF-α concentrations were determined in LPS-challenged pigs 24 h prior and 4 h post-LPS challenge. There was no interaction between treatment and time for change in body temperature (P > 0.10). Overall, increasing the O3 trial feed did not affect (P > 0.10) ADG, ADFI, G:F, IL-1ß, or TNF-α. In experiment 2, 1,056 pigs (PIC TR4 × [Fast LW × PIC L02] initially 7.3 kg) were used. Pens of pigs were randomly assigned to one of the four dietary treatments containing increasing omega-3 fatty acids (0%, 0.75%, 1.5%, and 3% O3 trial feed) with 12 replications per treatment. Oral fluids tested negative on days 7 and 14, but then positive for North American PRRSV virus via PCR on days 21, 28, 35, and 42. Overall, increasing O3 trial feed increased (linear, P < 0.001) ADG, ADFI, and G:F and decreased (linear, P = 0.027) total removals and mortality. In experiment 3, 91,140 pigs (DNA 600 × PIC 1050; initially 5.1 kg), originating from PRRSV-positive sow farms, were used across eight nursery sites. Each site contained five barns with two rooms per barn and ~1,100 pigs per room. Rooms of pigs were blocked by nursery site and allocated within sow source to one of the two dietary treatments (control or 3% O3 trial feed) with 40 replications per treatment. Oral fluids from 61 of the 80 rooms tested positive for North American PRRSV virus 1 wk postweaning and 78 of the 80 rooms tested positive 3 wk after weaning. Overall, O3 trial feed did not affect ADG, ADFI, or G:F but increased (P < 0.001) total removals and mortalities. In summary, increasing omega-3 fatty acids, sourced by O3 trial feed, did not improve growth performance or immune response in healthy pigs given an LPS challenge. However, it appears that if omega-3 fatty acids are fed prior to a natural PRRSV break (as in experiment 2), growth performance may be improved, and mortality reduced.

Effects of fat source and level on growth performance and carcass characteristics of commercial finishing pigs.

Two experiments evaluated different fat sources and levels on growth performance, carcass characteristics, and economic impact in commercial finishing pigs. In experiment 1, 2,160 pigs (337 × 1,050, PIC; initially 37.3 ± 0.93 kg) were used. Pens of pigs were blocked by initial body weight and randomly assigned to one of four dietary treatments. Three of the four dietary treatments included: 0%, 1%, and 3% choice white grease. The final treatment contained no added fat until pigs were approximately 100 kg, and then a diet containing 3% fat was fed until marketing. Experimental diets were fed over four phases and were corn-soybean meal based with 40% distillers dried grains with solubles. Overall, increasing choice white grease decreased (linear, P = 0.006) average daily feed intake (ADFI) and increased (linear, P = 0.006) G:F. Pigs fed 3% fat only during the late-finishing phase (~100 to 129 kg) had similar G:F compared to pigs fed 3% for the entire study during the late-finishing phase, and intermediate G:F overall. Increasing fat tended to increase (linear, P = 0.068) hot carcass weight (HCW). Feed cost increased (linear, P ≤ 0.005) and income over feed cost decreased (linear, P ≤ 0.041) as choice white grease increased. In Experiment 2, 2,011 pigs (PIC 1,050 × DNA 600; initially 28.3 ± 0.53 kg) were used. Pens of pigs were blocked by location in the barn and randomly assigned to one of five dietary treatments arranged in a 2 × 2 + 1 factorial with main effects of fat source (choice white grease or corn oil) and level (1% or 3% of the diet) and a control diet with no added fat. Overall, increasing fat, regardless of source, increased (linear, P < 0.001) average daily gain (ADG), decreased (linear, P = 0.013) ADFI, and increased (linear, P < 0.001) G:F. Increasing fat increased (linear, P ≤ 0.016) HCW, carcass yield, and backfat depth. There was a fat source × level interaction (P < 0.001) in carcass fat iodine value (IV), where IV increased to a greater extent in pigs fed corn oil with only a small increase in IV in pigs fed diets with choice white grease. In conclusion, these experiments suggest that increasing fat from 0% to 3%, regardless of source, produced variable responses in ADG but consistently improved G:F. Increasing fat increased HCW, carcass yield, and backfat depth, but feeding diets containing corn oil increased carcass IV. With the ingredient prices used, the improvement in growth performance did not justify the extra diet cost from increasing fat from 0% to 3% in most situations.

Effects of Core Antigen Bacterin with an Immunostimulant on Piglet Health and Performance Outcomes When Challenged with Enteric and Respiratory Pathogens.

A total of 90 pigs, approximately one day of age, were used in a 42-day study to evaluate whether Endovac-Porci, a core antigen vaccine with an immunostimulant, provides piglets with broad-spectrum protection against the enteric and respiratory effects of Gram-negative bacteria. This study was a single-site, randomized, prospective, blinded, comparative placebo-controlled design. Individual pigs were randomly allocated to 1 of 2 treatments in a randomized design. An individual pig was considered the experimental unit for the farrowing phase (Study day 0 to 21), and the pen was considered the experimental unit for the nursery phase (Study day 21 to 42). Thus, there were 45 replications per treatment during the farrowing phase and 15 replications per treatment during the nursery phase. Treatments included a control product (saline; CP) and an investigational product (Endovac-Porci; IVP). On Study day 23, all pigs were challenged with enterotoxigenic Escherichia coli strain expressing K88 (F4) fimbriae and Pasteurella multocida. Individual pigs were weighed and feed consumption was measured to determine body weight gain, average daily gain, and feed-to-gain ratio. Clinical and fecal scores and overall health were recorded daily. Overall, administering the IVP to pigs led to an increase (p < 0.01) in body weight gain and average daily gain compared to pigs administered the CP. Pigs administered the IVP had reduced (p < 0.01) mortality compared to pigs administered the CP. There was a Study day × treatment interaction on clinical and fecal scores (p < 0.01). There was also a main effect of Study day where clinical and fecal scores increased (p < 0.01) as the Study day increased. Treatment also had an effect on clinical and fecal scores, where pigs administered the IVP had lower (p < 0.01) clinical and fecal scores compared to pigs administered the CP. In conclusion, administering pigs with the Endovac-Porci vaccination significantly improved the performance (i.e., body weight, body weight gain, and average daily gain) and health (i.e., clinical and fecal scores), while reducing the overall mortality in pigs challenged with E. coli K88 orally and Pasteurella multocida intranasally post-weaning. Results from this study suggest that Endovac-Porci could provide broad-spectrum protection against enteric and respiratory effects of Gram-negative bacteria in piglets.